+6%

est. 2Y upside i

HealthcareSeries A

Helping healthcare workers find their next career opportunity

Rank

#461

Sector

Healthcare Staffing & Recruitment Software

Est. Liquidity

~5Y

Data Quality

Data: Medium

DirectShifts presents a strong upside opportunity driven by its profitable business model, moderate competitive moat, and AI-powered platform addressing critical pain points in healthcare staffing.

Last updated: March 10, 2026

Bull (30%)+350%

DirectShifts leverages its AI platform and credentialing services to rapidly expand market penetration, capturing significant share in the fragmented healthcare staffing market. Strategic partnerships and product enhancements drive revenue to $100M+ by 2028, justifying a $1.35B+ valuation (4.5x current $300M) at acquisition or IPO, well above the current valuation.

Base (45%)+75%

DirectShifts maintains its competitive position, growing steadily by expanding its network of clinicians and employers. Revenue reaches approximately $50M by 2028, leading to an acquisition or IPO valuation of around $525M (1.75x current $300M), reflecting continued profitability and moderate growth in its core segments.

Bear (25%)-80%

Increased competition from well-funded rivals and potential entry of larger healthcare tech players erode DirectShifts' market share and pricing power. Regulatory changes or slower-than-expected adoption of its platform lead to stalled growth, forcing a down round or fire sale at a valuation of $60M (0.2x current $300M), severely impacting common stock value due to liquidation preferences.

Est. time to liquidity~5.0 years

Preference Stack Risk

high

Investors hold $85.2M in liquidation preferences, which represents 28.4% of the assumed current valuation of $300M.

Dilution Risk

moderate

As a Series A company, DirectShifts will likely require additional funding rounds to achieve significant scale, leading to further dilution for existing equity holders.

Secondary Liquidity

none

There is currently no active secondary market or tender offers for DirectShifts' equity, typical for a company at this stage.

View all 16 open roles at DirectShifts →

Last updated: February 17, 2026

Questions to Ask at the Interview

Strategic questions based on DirectShifts's data — designed to show you've done your homework.

  • 1

    “Given the fragmented nature of the healthcare staffing market and competitors like Clipboard Health and Medely, how does DirectShifts plan to sustain and expand its competitive moat, particularly against well-funded late-stage players?”

  • 2

    “With current revenue around $18M and a significant TAM, what are the key strategic initiatives and product roadmap priorities over the next 2-3 years to accelerate growth beyond the current 7% YoY weighted market growth?”

  • 3

    “Considering the Series A funding and the typical timeline for liquidity events, what is the company's anticipated path to IPO or acquisition, and how does the leadership team view future dilution risk for common stock holders?”

Community

Valuation Sentiment

Our model estimates +6% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.